粉样蛋白阳性和睡眠特征之间的关系在老年人与主观认知衰退的老年人
Kyung Joon Jo1, SeongHee Ho2, Yun Jeong Hong3
1Department of Neurology, College of Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Dementia and neurocognitive disorders
|February 16, 2024
概括
在认知上正常的老年人中,有粉样质斑块的老年人显示慢波睡眠 (SWS) 减少. 这种早期阿尔茨海默病 (AD) 生物标志物可能在症状出现之前表明睡眠模式发生了变化,因此需要进一步调查SWS在AD病理学中的作用.
科学领域:
- 神经科学是一个神经科学.
- 睡眠医学 睡眠医学
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,影响认知和日常功能.
- 改变睡眠特征可能会在患有AD病理的个体之前出现临床症状.
- 这项研究调查了具有和没有粉样蛋白负担的认知无症状个体的睡眠差异.
研究的目的:
- 为了评估认知无症状的个体与没有粉样蛋白负担之间的睡眠特征差异.
- 在睡眠模式中识别阿尔茨海默病的潜在早期生物标志物.
- 为了探索粉样蛋白沉积和老年人睡眠质量之间的关系.
主要方法:
- 研究了76名主观认知衰退 (SCD) 但没有轻度认知障碍 (MCI) 或AD的受试者 (≥60岁).
- 使用Fitbit® Alta HR可穿戴设备监测睡眠特征.
- 通过大脑粉样蛋白斑块负荷 (BAPL) 和正子发射断层扫描 (PET) 评估了粉样蛋白沉积.
主要成果:
- 在76名受试者中,有15名被确定为粉样蛋白阳性.
- 与粉样蛋白阴性个体相比,粉样蛋白阳性个体在慢波睡眠 (SWS) 中花费的时间显著减少 (39.4分钟对49.5分钟,p=0.009).
- 摘要中没有详细说明其他睡眠指标的显著差异.
结论:
- 慢波睡眠 (SWS) 持续时间在主观认知衰退 (SCD) 的老年人之间有所不同,他们是粉样蛋白阳性与粉样蛋白阴性.
- 这些发现表明,SWS可能是与大脑中的粉样蛋白负担相关的早期指标.
- 需要进一步的研究来阐明SWS影响阿尔茨海默病病理学的确切机制.
相关概念视频
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Understanding Sleep
228
Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
228
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
REM Sleep Behavior Disorder
184
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
184


